Search -

Displaying 1 - 20 of 40

Sort: Relevancy | Date

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

Presentation TCT India 2025

Introduction to MyClip: Transcatheter Edge to Edge Repair System

Presenter: Anil Yadav & Viveka Kumar

July 27, 2025

News Daily News

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Yael L. Maxwell

February 25, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

Presentation THT 2025

Implantable Cardiac Patch Continuously Monitors Inflammation and Acute Heart Failure Biomarkers In Vivo and Ex Vivo

Presenter: Devleena Das

February 13, 2025

Presentation Controversies and Advances 2025

Changing ABO Blood Type During Ex Vivo Perfusion

Presenter: Fardad Esmailian

January 31, 2025

News Conference News AHA 2024

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Yael L. Maxwell

November 20, 2024

Presentation THT 2024

Ex Vivo Gene Therapy in Cardiac Allografts

Presenter: Dawn E. Bowles

March 06, 2024

Presentation THT 2024

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

Presenter: Eduardo Rame

March 06, 2024

Presentation THT Abstracts 2024

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Presenter: Vivek Jha

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

Shelley Wood

November 30, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News TVT 2023

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Shelley Wood

June 14, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News AHA 2022

CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis

Yael L. Maxwell

November 05, 2022

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

Presentation THT 2022

The Intersection Between EP and Heart Failure

Presenter: Vivek Reddy

February 02, 2022

News Daily News

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

Michael O'Riordan

January 12, 2022

News Industry News

Affera, Inc. Announces Successful First-In-Human Use of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

July 27, 2021

Advertisement

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Introduction to MyClip: Transcatheter Edge to Edge Repair System

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Implantable Cardiac Patch Continuously Monitors Inflammation and Acute Heart Failure Biomarkers In Vivo and Ex Vivo

Changing ABO Blood Type During Ex Vivo Perfusion

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Ex Vivo Gene Therapy in Cardiac Allografts

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

TCTMD’s Top 10 Most Popular Stories for November 2023

What’s Going to Be Hot at TCT 2023

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis

Valve Fracture for ViV TAVI Linked With Higher Mortality

The Intersection Between EP and Heart Failure

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

Affera, Inc. Announces Successful First-In-Human Use of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content